Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 846

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Status epilepticus

Not recruiting

Study on Treating Status Epilepticus in Seniors Using Levetiracetam and Valproate Semisodium

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Valproate Semisodium

Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Mecasermin Rinfabate

Systemic mastocytosis+1

Not recruiting

Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Study of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Cardiac arrest

Not recruiting

Study on the Effects of Dexamethasone and Olanzapine in Patients Resuscitated from Out-of-Hospital Cardiac Arrest

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Myocardial infarction

Not recruiting

Study on Prasugrel or Ticagrelor for Patients with Atrial Fibrillation and Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid

Breast cancer+1

Not recruiting

Study on Cyclophosphamide for Patients with Advanced Breast Cancer with TP53 Mutations

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years

Study of Ramucirumab and Dacarbazine for Patients with Progressive Metastatic Pancreatic Neuroendocrine Tumors

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Plasma cell myeloma

Not recruiting

Study Comparing Selinexor, Pomalidomide, and Dexamethasone with Elotuzumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Selinexor

Gastrooesophageal cancer+1

Not recruiting

Study of Pembrolizumab, Trastuzumab, and Drug Combination for Patients with HER2-Positive, Localized Esophagogastric Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Study of isatuximab, belantamab mafodotin and dexamethasone combination for patients with relapsed or refractory multiple myeloma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.